pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
Vanish Trial
Phase 3 · small molecule · People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.
Vanish Trial for People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation. is a Phase 3 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Internal code Vanish Trial
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.
- Status
- active
- Trials
- 1